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Background: Non-B cell immunoglobulins (Igs) are widely expressed in epithelial cancer cells. The past 20 years of
research have demonstrated that non-B cell Igs are associated with cancer cell proliferation, the cellular cytoskeleton
and cancer stem cells. In this study we explored the transcriptional mechanism of IgM production in non-B cells.
Methods: The promoter region of a V-segment of the heavy mu chain gene (VH6-1) was cloned from a colon cancer
cell line HT-29. Next, the promoter activities in non-B cells and B-cells were detected using the dual-luciferase reporter
assay. Then the transcription factor binding to the promoter regions was evaluated by electrophoretic mobility
shift assays (EMSAs) and gel supershift experiments.
Results: Our data showed that the sequence 1200 bp upstream of VH6-1 exhibited promoter activity in both B
and non-B cells. No new regulatory elements were identified within the region 1200 bp to 300 bp upstream of
VH6-1. In addition, Oct-1 was found to bind to the octamer element of the Ig gene promoter in cancer cells, in
contrast to B cells, which utilize the transcriptional factor Oct-2.
Conclusion: The regulatory mechanisms among different cell types controlling the production of IgM heavy chains
are worth discussing.
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Immunoglobulins (Igs) are important immune molecules
that are produced when B cells transition into plasma
cells. As unique molecules produced by B cells, Igs are
also referred to as B cell receptors (BCRs) and play a role
in antigen recognition. However, Qiu et al. found that Igs,
including IgG, IgA and IgM, are also widely expressed in
other types of cells such as normal or cancer cells derived
from epithelial tissue, mesenchymal tissue cells and blood
myeloid cells and that they are implicated in cell prolifera-
tion and carcinogenesis [1,2]. The phenomenon of non-B
cells expressing Igs has been confirmed elsewhere [3-7].
Babbage et al. noted the presence of functional transcripts
of Ig variable (V), diversity (D) and joining (J) rearrange-
ments in four out of six breast cancer cell lines and
sequential cultures, indicating stable expression. These cell* Correspondence: qiuxy@bjmu.edu.cn
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unless otherwise stated.lines expressed activation-induced cytidinedeaminase
(AID), which is essential for mutational and switch activity
[8]. Additionally, using a rat model of breast cancer,
Adamovic et al. found that the Ig heavy chain variable
region gene is closely associated with breast cancer [9].
Regulation of transcription is thought to involve the
interplay between tissue- and developmental-specific tran-
scription factors (TFs), which act upon enhancer and
promoter sequences to facilitate the assembly of the
transcription machinery at gene promoters. The recom-
bined IgH gene has a relatively simple promoter (referred
to as the VH promoter) that is comprised primarily of a
conserved TATA box at approximately −30 bp and a highly
conserved DNA sequence element (the octamer) at ap-
proximately −70 bp relative to the transcription start site
[10]. The octamer element is usually located within 100 bp
of the transcription initiation site for all VH and Vk pro-
moters [11]. A point mutation in the octamer DNA motif
reduced the expression of an Ig transgene by more than
20-fold, as shown in a previous study utilizing transgenic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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been shown to bind the octamer motif, including both
Oct-1 and Oct-2 [13,14]. While Oct-2 is B cell specific and
is known to be a major tissue-specific regulator of Ig tran-
scription, Oct-1 is ubiquitously expressed in non-B cells
and regulates the expression of housekeeping genes such as
histone H2B and snRNA via recognition of the conserved
octamer element.
B cell-specific IgH regulation is well characterized, but
the regulation of IgH in non-B cells remains unclear.
Based on our initial data, which demonstrated that Ig VH
genes were frequently expressed in epithelial cancer cells,
we undertook a series of studies to explore the mecha-
nisms underlying non-B cell Ig expression. Expression
of the VH4-59 segment, a component of IgG heavy chain,
was detected in several epithelial cancer cell lines and was
found to be driven by Oct-1 [15]. IgM heavy chain ex-
pression was present in some primary epithelial cancer
cells and epithelial cancer cell lines, and, interestingly,
these IgM heavy chains preferentially selected another
VH6-1 segment [16]. In this study, we explored the regula-
tory mechanisms responsible for Ig VH6-1 gene tran-
scription in epithelial cancer cells. We constructed a 5′
upstream 1200-bp fragment of VH6-1 containing the
IgH promoter and found that it exhibited promoter ac-
tivity in all non-B cell lines tested except Jurkat. Unlike
the upstream VH4-59 promoter, which contains two novel
up-regulatory elements, we detected no novel regulatory
element within the region 300 bp to 1200 bp upstream of
the VH6-1 promoter in non-B cell cell lines. In addition,
we found that Oct-1 but not Oct-2 was a key TF for
VH6-1 gene transcription in non-B cells. This observa-
tion suggests that the regulatory mechanism of IgG heavy




The ten cell lines used in this study were supplied by the
Peking University Center for Human Disease Genomics.
HeLa, HeLa MR, HeLa S3 (all human cervical cancer cell
lines), HT-29 (a human colon cancer cell line), MDA-
MB-231 (a breast cancer cell line), HEK293 (A human
embryonic kidney cell line), HK2 (an immortalized
proximal tubule epithelial cell line) and L02 (a human
embryonic liver cell line) were cultured in DMEM
(Gibco/Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum (FBS) (Hyclone/Thermo Fisher
Scientific, Pittsburgh, PA) and 2 mM glutamine. Raji and
Daudi (a B lymphocytic leukemia cell line) and Jurkat
(T lymphocytic leukemia cell line) cells were cultured in
RPMI 1640 medium (Gibco) supplemented as described
above. All of the cells were maintained in an incubator
with 5% CO2 at 37°C.Construction of reporter constructs
For the construction of reporter constructs, a fragment
containing the human Ig VH6-1 gene core promoter
element (including the atypical octamer motif ) was
amplified from the HT-29 cell line using the following
primers: 5′-GGGGTACCCACACAGTGCAGTTTCCA
CGT-3′ (forward) and 5′-GCGAGATCTCTGGTGACT
GCCCTGGTC-3′ (reverse). After sequencing to con-
firm the fragment, the PCR product was subcloned into
the pGL3 vector (Promega, Madison, WI) to create a
1.2-kb pGL3 luciferase reporter plasmid (pGL3-1.2 kb).
A 300-bp version of pGL3 (pLG3-300 bp) was generated
from the 1.2-kb pGL3 by PCR amplification using the for-
ward primer 5′-GGGGTACCTTTGGTTGATAGGACGC
C-3′ and the reverse primer 5′-GCGAGATCTCTGGT
GACTGCCCTGGTC-3′. To detect the activity of the
octamer element, four base pairs located in the middle
of the octamer motif (AGGCAAAT), which is present in
the promoter region of the VH6-1 gene, were deleted using
the QuikChange site-directed mutagenesis kit (Stratagene/
Agilent Technologies, La Jolla, CA,USA). The constructs
containing the GCAA deletion were designated as the
pGL3-1.2 kb-mt. The sequences of the constructs were
confirmed by DNA sequencing.
Transient transfection
For assays using the pGL3 reporter plasmids, the pGL3
construct was cotransfected with the internal control
plasmid pRL-TK (Promega). Firefly and renilla luciferase
activities were measured with a dual-luciferase reporter
assay kit (Promega). A 20-ms electrical pulse at 120 V
was delivered to HeLa, HeLa MR and HeLa S3 cells,
while 130 V was delivered to HT-29 cells and 140 V
was delivered to Raji and Jurkat cells. After standing at
room temperature for 10 min, the transfected cells were
allowed to recover at 37°C in DMEM or RPMI-1640
culture medium supplemented with 10% FBS for approxi-
mately 30 h in 24-well culture plates. MDA-MB-231,
HEK293, L02 and HK2 were transfected with lipofetamine
2000 for 24 h. Luminescence was measured using a Veri-
tasmicroplateluminometer (Turner Biosystem, Sunnyvale,
CA, USA). Relative luciferase activity was calculated by
measuring the ratio of firefly to renilla luciferase activities.
RT-PCR
Total RNA was extracted from HT-29, HeLa S3, Jurkat
and Daudi cells using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA). Reverse transcription (RT) of total RNA from
each of these samples was performed using a Superscript
II RT kit (Invitrogen) according to the manufacturer’s in-
structions. The Oct-2 gene was amplified using the forward
primer 5′-CCTGCTCAGTTCCTGCTACC-3′ and the re-
verse primer 5′-GATGCTGGTCCTCTTCTTGC-3′. The
PCR reaction for Oct-2 amplification was carried out
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94°C for 30 sec, 54°C for 30 sec and 72°C for 30 sec, finish-
ing with a one-cycle extension step at 72°C for 7 min. PCR
products were separated via electrophoresis in a 1.0% agar-
ose gel and visualized by ethidium bromide (EB) staining.
Electrophoretic mobility shift assays (EMSAs) and gel
supershift experiments




TGC-3′ were synthesized with 3′ overhangs, annealed and
end-labeled with DIG (second-generation DIG gel shift kit;
Roche, Basel, Switzerland). Briefly, after each treatment,
cells were harvested and washed twice with cold PBS.
The cell pellets were resuspended in 400 μl of cold buffer
A (10 mMHepes, 10 mMKCl, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM DTT, 0.5 mM PMSF, pH 7.9). The cells
were allowed to swell on ice for 15 min, then 25 μl of
10% NP-40 was added, and the tubes were vortexed
vigorously for 10 s. The homogenates were centrifuged
at 10,000 g for 30 s. The nuclear pellets were resus-
pended in 50 μl of ice-cold buffer B (20 mMHepes,
0.4 M NaCl, 1 mM EDTA, 1mM EGTA, 1 mM DTT,
1 mM PMSF, pH 7.9). After vigorously shaking at 4°C
for 15 min, the nuclear extracts were centrifuged at
10,000 g for 5 min at 4°C, and the supernatants were
collected. The protein concentrations were determined by
Bradford analysis. EMSAs were performed using nuclear
extracts from HT-29 cells according to the manufacturer’s
instructions (Chemiluminescent Nucleic Acid Detection
Module, Thermo Fisher/Pierce, Rockford, IL, USA).
Supershift assays were performed by preincubating nuclear
extracts with 1 μl polyclonal anti-Oct-1 or anti-Oct-2 anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
at room temperature for 20 min prior to adding the DNA
probes.
Chromatin immunoprecipitation
In brief, after crosslinking for 30 min with 1% formal-
dehyde, glycine was added to a final concentration of
125 mM and incubated for 5 min at room temperature.
After then incubating at room temperature for 20 min
and then at 4°C overnight with gentle agitation, the cells
were rinsed twice in PBS, trypsinized, and lysed for 10 min
on ice in cell lysis buffer (50 mMHepes-KOH, 140 mMNaCl,
1 mM EDTA, 1% Triton X-100, 10% glycerol, 0.5% NP-40,
freshly added protease inhibitors, pH 7.5). After centrifuging
at 4,000 rpm at 4°C for 10 min, the nuclei in the pellets were
resuspended in nuclear lysis buffer (200 mMNaCl, 1 mM
EDTA, 0.5 mM EGTA, 10 mMTris, freshly added protease
inhibitors, pH, 8.0) on ice for 10 min. The chromatin
was sheared by sonication to an average DNA sequencelength of 300–1,000 bp. Each sample was subjected to
pre-clearance for 2 h by incubation with protein G-
sepharose beads (50% slurry) at 4°C. The pre-cleared
samples were incubated with 1.5 mg of anti-Oct-1 at 4°C
overnight followed by incubation with 20 ml of pre-blocked
protein G beads (50% slurry) at 4°C for 2 h. The precip-
itates were washed with washing buffer (50 mMHepes,
140 mMNaCl, 1 M EDTA, 1% Triton X-100, 0.1% DOC,
freshly added protease inhibitors, pH 7.5) five times and
were then resuspended in 100 μl of TE buffer. The
combined eluates as well as the input samples (2% of
the amount used in the IP procedure) were reverse
crosslinked by heating overnight at 65°C in the pres-
ence of 200 mMNaCl. After proteinase K digestion, the
chromatin fragments were purified, and a 2-μl aliquot was
used in each PCR reaction with primer sequences that
amplified a 220-bp DNA fragment containing the octamer
motif located in the IgH promoter of VH6-1 (forward se-
quence, 5′-GCTGAAGAACATGGCTCTAGG-3′; reverse
sequence, 5′-TGTCTGGAGCTCTGGTGACTG-3′). PCR
products were separated by electrophoresis in a 1.0%
agarose gel and visualized by EB staining.Statistical analysis
Data are expressed as the mean ± standard error (SE)
using the GraphPad prism software program (GraphPad
Software, La Jolla, CA, USA). All data were obtained from
at least duplicate measures for at least three separate and
independent experiments.Results
The 1200 bp fragment upstream of VH6-1 exhibits promoter
activity in non-B cells
The Ig VH core promoter is primarily composed of a
conserved TATA box and the octamer element that is
located within 100 bp of the transcriptional start site.
We first amplified the upstream 1.2-kb DNA fragment
of VH6-1 from HT-29 (a colon cancer cell line) by PCR
and cloned this fragment into a pGL3 luciferase reporter
vector named pGL3-1.2 kb (Figure 1A&B). To examine
the promoter activity of pGL3-1.2 kb, dual-luciferase re-
porter assays were performed in ten cell lines, including
HT-29, three cervical cancer cell lines HeLa, HeLa MR
and HeLa S3,a breast cancer cell line MDA-MB-231, three
immortalized diploid cell lines HEK293, L02 and HK2,
Raji cells as a positive control and Jurkat cells as a negative
control. The 5′ flanking sequence of VH6-1 demonstrated
higher promoter activity in nine cell lines than the pGL3
control and even exhibited higher activity than the Simian
Virus 40 (SV40) promoter, which demonstrated high activ-
ity in mammalian cell lines (Figure 1C). As expected, the
1.2-kb construct exhibited no activity in Jurkat cells.
Figure 1 The 5′-flanking sequence of VH6-1 exhibits promoter activity in non-B cancer cells. (A) Schematic diagram of 5′-flanking 1.2-kb
pGL3 construct. (B) The 1.2-kb fragments amplified from upstream of VH6-1 in HT-29 cells by PCR. (C) The 1.2-kb pGL3 construct was transfected
into HeLa, HeLa MR, HeLa S3, HT-29, MDA-MB-231, HEK 293,L02, HK2, Raji or Jurkat cells. Luciferase activity was measured using a dual-luciferase
reporter system. The results are representative of three independent experiments after normalization to renilla luciferase activity (internal controls).
Each bar represents mean ± SD.
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There is an atypical octamer sequence in VH6-1 (AGG
CAAAT) that deviates from the typical sequence (ATG
CAAAT). To ascertain the function of the octamer el-
ements located in the Ig VH6-1 promoter, a mutated
plasmid (pGL3-1.2 kb-mt) was constructed by deleting
the middle four base pairs of the octamer element
(Figure 2A). Unexpectedly, the deletion construct still
exhibited promoter activity, although the activity was
lower than for the construct that included the complete
promoter construct pGL3-1.2 kb in all five cancer cells,
three immortalized diploid cells and Raji cells (Figure 2B).
These results indicated that the octamer element of VH6-1
in non-B cells is important but not essential.The sequence 1200 bp to 300 bp upstream of VH6-1
contains no regulatory elements
It was previously shown that the region 1200 bp to
300 bp upstream of VH4-59 contains two regulatory ele-
ments [15]. To determine whether regulatory elements
exist in the sequence upstream of the VH6-1 promoter,
the 1200-bp region containing the VH6-1 promoter was
deleted via PCR (Figure 3A&B). The promoter activity
of the deletion construct (pGL3-300 bp) was tested using
a dual-luciferase reporter assay. Strong promoter activity
was observed for both the 1200bb and 300-bp constructs
in HT-29 and Raji cells, and the promoter activities of
both were higher than for the SV40 promoter (Figure 3C).
It is likely that there are no regulatory elements upstream
(between 1200 bp and 300 bp) of the promoter of VH6-1
Figure 2 The octamer element is important but not essential for non-B cell-derived Ig gene transcription. (A) Schematic diagram of
mutated 5′ deletion truncations of the 1.2-kb pGL3 construct with a 4-bp deletion in the octamer motif (AGGCAAAT). (B) The intact and mutated
5′ deletion truncations of the 1.2-kb pGL3 construct were transfected into HeLa, HeLa MR, HeLa S3, HT-29, MDA-MB-231, HEK 293, L02, HK2, and
Raji cells. Luciferase activity was measured using a dual-luciferase reporter system. The results are representative of three independent experiments after
normalization to renilla luciferase activity (internal controls). Each bar represents mean ± SD.
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ing the expression of VH6-1 and VH4-59 are different.
Oct-1, but not Oct-2, regulates VH6-1 promoter activity
It is known that Oct-2 binds to the octamer element in
mature B lymphocytes to initiate the expression of Ig.
The Oct-2 transcript was not detected by RT-PCR in
HeLa S3, HT-29 and Jurkat cells, compared with Daudi
cells as a positive control (Figure 4A). Next, EMSAs were
performed to evaluate the binding of TFs to the octamer
element of the Ig VH6-1 gene in epithelial cancer cells. Nu-
clear protein fractions from HT-29 cells interacted with
octamer elements of the VH6-1 upstream region, appearing
in a non-denaturing electrophoresis hysteresis band.
Compared with the 40-bp double-stranded oligonucleotides
containing the octamer motif, the hysteresis band disap-
peared for the 32-bp oligonucleotides that did not containan octamer motif, indicating that this interaction was
specific (Figure 4B). The anti-Oct-1 antibody strongly
super-shifted the binding complex of the HT-29 nuclear
proteins, which indicated that no hysteresis band was de-
tected because the DNA binding to the antibody-protein
complex did not exit through holes (Figure 4C). These
results also indicated that Oct-1 interacts with the octa-
mer element to promote Ig VH6-1 expression in HT-29
cells.
To confirm that the endogenous Ig VH6-1 promoter was
bound by endogenous Oct-1, ChIP assays were performed
with Oct-1-specific antibodies. The VH6-1 promoter could
be amplified from immunoprecipitated complexes obtained
with anti-Oct-1 antibodies but not from control complexes
in the absence of an antibody (Figure 4D). Oct-1 therefore
bound the endogenous octamer element for Ig VH6-1 tran-
scription in HT-29 cells.
Figure 3 The sequence 1200 bp to 300 bp upstream of VH6-1 contains no regulatory elements. (A) Schematic diagram of 5′-flanking 300-bp
pGL3 construct. (B) The 300-bp deletion fragment amplified from the 1.2-kb fragment containing the VH6-1 promoter by PCR. (C) The 300-bp deletion
truncations of the 1.2-kb pGL3 construct exhibited similar promoter activity to the 1.2-kb pGL3 construct in HT-29 and Raji cells.
Figure 4 Oct-1 but not Oct-2 binds to the octamer element. (A) Oct-2 was not detected in epithelial cancer cells by RT-PCR. (B) The EMSA
assay for octamer motif binding factors located in the promoter region of VH6-1 in HT-29 cells. The 40-bp DNA fragment was derived from upstream
of the VH6-1 gene and contains the octamer motif, while the 32-bp DNA fragment was derived from the 40-bp DNA fragment with an 8-bp deletion
in the octamer motif. (C) The super-shift assay for octamer motif binding factors with the addition of an anti-Oct-1 or anti-Oct-2 antibody in
the binding reaction system. The results are representative of three independent experiments. EMSA, electrophoretic mobility shift assay. (D) The Oct-1
binding DNA fragment of the VH6-1 promoter was amplified via Chip-related PCR. Negative control: no template in the PCR reaction system; positive
control: the sonicated chromatin fragments of the cells were used as the PCR template; control group: no antibody added to the IP system; test group:
dilutions of IP were used as templates for PCR to amplify the Oct-1 binding DNA sequence. The results are representative of three independent
experiments.
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In 1996, Qiu et al. found that IgG was expressed in breast
cancer cells, and the past 20 years of research have shown
that IgG is widely expressed in almost all epithelial carcin-
omas and epithelial cancer cell lines, as well as in some
normal epithelial cells, neurons and germ cells from pa-
tients without cancer and in healthy mice [2,17,18]. More-
over, cancer-derived Ig heavy chains exhibited differential
repertoires for the gamma chain and the mu chain in the
same cells. The Ig VH5-51, VH4-59 and VH3-30 genes
were frequently used by the gamma chain, and the VH6-1
gene was frequently used by the mu chain in epithelial
cancer cells [16]. The classical theory that Igs are the
unique products of B cells has been challenged by these
observations. However, the detailed mechanisms of non-B
cell Ig production remain unclear.
In B lymphocytes, recombinatorial IgH transcriptional
regulation primarily involves a looping mechanism for
enhancer-promoter communication. It was thought that
transcription of the Ig gene was silenced in non-B cells.
In 1994, Sun et al. discovered that the VH6-1 promoter
was very active in HeLa cells. Because this was inconsist-
ent with classical immunoglobulin theory, they speculated
that the VH6-1 promoter did not possess tissue specificity
and that opening of the chromatin in this area upstream
of the diversity region may specially require the product
of the VH6 transcript [18]. However, our data, and those
of other investigators, showed that functional transcripts
of Ig VDJ rearrangements were present in both primary
cancer cells and cancer cell lines such as HeLa [16].
In our previous study, by immunohistochemistry, we
detected IgM expression in many epithelial cancer tissues
and their corresponding normal tissues, and found that
IgM was expressed in epithelial cancer cells with a high
frequency than that in normal epithelial cells although
IgM was expressed in both epithelial normal or cancer
cells [19]. In our study, the VH6-1 promoter derived from
HT-29 cells was very active in several epithelial cancer cell
lines and immortalized diploid cells, indicating that Ig VH
genes were located in the open chromatin DNA region
and that non-B cells can also drive Ig gene transcription.
Maybe the promoter activity of VH6-1 can be revealed in
some normal cells in the body with a lower level than that
in their corresponding cancer cells.
In addition to the core promoter elements that include
the consensus TATA box and the Inr element, the hall-
mark of all VH promoters is the presence of an octamer
element. The best-characterized IgH enhancers are intronic
(Eμ) enhancers located between the 3′-most joining (J) and
constant μ (Cμ) regions and 3′ enhancers (located down-
stream of Cα, here referred to as the 3′-RR) that are spread
over a 30-kb region. The remarkable conservation of the
octamer element in both Ig light and heavy chain gene pro-
moters, together with its appearance in both Eμ and 3′-RR,has led to the assumption that transcription factor in-
teractions with this element are crucial for regulation of Ig
genes. B cell-specific TF binding to the octamer element
occurs with Oct-2. With EMSA and ChIP assays, we
found that Oct-1, but not Oct-2, bound to the atypical
octamer element (5′-AGGCAAAT-3′) of VH6-1 in cancer
cell lines. However, we confirmed that although the octa-
mer element was very important for Ig VH6-1 gene tran-
scription in HT-29 cells, high promoter activity was also
present when the octamer element was deleted. This
result suggests that, unlike previous assumptions, there
are other unidentified regulatory elements within the
upstream 300-bp region in both B cells and non-B cells.
In previous studies, we found two positive regulatory
elements in the upstream promoter region of VH4-59
in epithelial cancer cell lines but not in B cells that were
used as positive controls [15]. Utilizing a series of 5′ flanking
sequences of the VH6-1 promoter, we observed that
unlike VH4-59, no other activation elements are located
within 1200 bp to 300 bp upstream of the VH6-1 promoter,
which is similar to that found in B cells. Therefore, it is
worth investigating the functions and mechanisms of action
of additional TFs involved in Ig gene transcriptional regula-
tion in non-B cells.
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